Lanean...
Update in the medical therapy of Cushing’s disease
PURPOSE OF REVIEW: Recently developed agents treat Cushing’s disease by inhibiting adrenocorticotropic hormone (ACTH) secretion from corticotrope tumors or antagonizing cortisol action. RECENT FINDINGS: The dopamine agonist cabergoline and the somatostatin agonist pasireotide target ACTH secretion....
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4215263/ https://ncbi.nlm.nih.gov/pubmed/23807605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0b013e3283631809 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|